What question did this study set out to answer?

The aim is to provide comprehensive supplementary data supporting the investigation of GLX10 as a therapeutic for type 2 diabetes.

April 21, 2026Open Access

GLX10 Supplementary Data and Experimental Datasets for Type 2 Diabetes Study

Read Full Paperexternally

Key Points

The aim is to provide comprehensive supplementary data supporting the investigation of GLX10 as a therapeutic for type 2 diabetes.
Included oral glucose tolerance test curves and longitudinal blood glucose data
Body weight measurements and detailed experimental protocols were analyzed
Supplementary figures illustrate experimental findings
Data show variations in blood glucose levels across the oral glucose tolerance tests
Longitudinal analysis indicates trends in body weight measurements over time
Western blot and ELISA data support the immunometabolic effects of GLX10

Abstract

This dataset contains supplementary figures, experimental data, and extended methodological details supporting the study on GLX10 as an investigational immunometabolic therapeutic approach in type 2 diabetes mellitus. Included materials:- Supplementary Figures (S1–S10)- Oral glucose tolerance test curves- Longitudinal blood glucose data- Body weight measurements- Western blot and ELISA data- Detailed experimental protocols These materials are provided to ensure transparency, reproducibility, and scientific validation of the findings.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Sherif Salah

Actions

Institutions

Cairo University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

GLX10 Supplementary Data and Experimental Datasets for Type 2 Diabetes Study

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study